Focus on Diabetes-logo

Focus on Diabetes

ReachMD

ReachMD takes an in-depth look at diabetes, a disease identified in nearly 1 in 10 Americans, which upsets the lives of millions more. Tune in to gain insights for your practice.

ReachMD takes an in-depth look at diabetes, a disease identified in nearly 1 in 10 Americans, which upsets the lives of millions more. Tune in to gain insights for your practice.
More Information

Location:

United States

Networks:

ReachMD

Description:

ReachMD takes an in-depth look at diabetes, a disease identified in nearly 1 in 10 Americans, which upsets the lives of millions more. Tune in to gain insights for your practice.

Language:

English


Episodes

When Insulin Isn’t Enough: Exploring Dual SGLT1 and SGLT2 Inhibition in T1DM

10/15/2018
More
Host: Shira Johnson, MD Guest: Anne Peters, MD Guest: Donna Miller, MSN, FNP-C, CDE Guest: Jana Conley This activity explores new and emerging treatments for type 1 diabetes, including a dual sodium glucose transporter 1/2 inhibitor, and provides both clinician and patient perspectives on their use.

Duration:00:19:29

The P4 Approach: Predictive, Preventive, Personalized and Participatory Medicine

9/25/2018
More
Host: Rishi P. Singh, MD Guest: Arshad Khanani, MD Guest: Ehud Ur, MD Guest: David Boyer, MD Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options for efficient, accurate and reproducible diagnosis and monitoring of ocular conditions. Likewise, diabetes management guidelines and strategies, including pharmacologic treatments and devices, have also evolved, underscoring the importance of...

Duration:00:53:29

Is a Low-Carb High-Fat Diet the Key to Diabetic Management?

3/5/2018
More
Host: Barnett Mennen, MD Guest: Sarah Hallberg, MD Carbohydrates are our main source of energy and provide important nutrients for good health. However, they are also the main culprit behind elevated blood sugar and are problematic for diabetic patients trying to control their blood sugar levels. Host Dr. Barry Mennen sits down with Dr. Sarah Hallberg to talk about carbohydrate restriction as a key to successful weight loss programs. She prescribes that adherence to a low-carb, high-fat...

Duration:00:11:29

Diabetes and Cardiovascular Risk: New Thinking, New Opportunities

2/28/2018
More
Host: John J. Russell, MD Guest: John (Jack) L. Leahy, MD Diabetes is a major global health emergency, affecting approximately 415 million adults and contributing to five million deaths each year. Cardiovascular disease is a serious complication of type 2 diabetes mellitus (T2DM), contributing to the majority of morbidity and mortality in this population. In recent years, the cardiovascular impact of anti-diabetes medications has become the focus of research. Recent findings from...

Duration:00:28:29

Improving Glycemic Control: Reducing Patient Burden, The Rationale for Concentrated Insulins in Type 2 Diabetes Mellitus

1/23/2018
More
Host: John J. Russell, MD Guest: Anne Peters, MD, CDE Many patients with type 2 diabetes mellitus cannot be controlled with standard insulin agents due to obesity, insulin resistance, high risk of hypoglycemia, low adherence due to high injection burden, and the need for frequent glucose monitoring. Drs. Peters and Russell will review patient cases, and share practical information on concentrated insulins, including criteria for selection, switching strategies and dosing regimens,...

Duration:00:14:29

Enhancing Adherence to Maintain Glycemic Control in Patients with Type 2 Diabetes

11/28/2017
More
Host: Matt T. Rosenberg, MD Guest: Monica E. Peek, MD, MPH, MSC Attaining and maintaining glycemic control continues to be very difficult for patients with type 2 diabetes. Please join Drs. Matt T. Rosenberg and Monica E. Peek as they discuss these issues.

Duration:00:16:00

FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin

5/16/2017
More
Based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (brand names Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. The FDA is requiring new warnings, including their most prominent Boxed Warning, be added to the canagliflozin drug labels to describe this risk. Amputations of the toe and middle of the foot were the most common; however, amputations involving the leg, below and above the...

Duration:00:03:00

The Rising Diabulimia Epidemic: Safeguarding Diabetic Patients with Eating Disorders

12/19/2016
More
Host: Brian P. McDonough, MD, FAAFP Diabulimia, defined as the manipulation of insulin treatments by Type 1 diabetic patients in order to lose weight, is a rising problem among teens and young adults in the U.S, particularly young women. Joining Dr. Brian McDonough to discuss this dual diagnosis phenomenon of diabetes and eating disorders, ways in which they exacerbate other disease processes, the long term consequences, and management priorities for phycisians is author and registered...

Duration:00:13:30

Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods

5/30/2016
More
[Read the Article] Despite targeted efforts to reduce obesity through diet and exercise, these rates continue to rise. A new study from Ontario, Canada found that obesity and diabetes rates were lower in more walkable neighborhoods compared to less walkable neighborhoods, where they saw an increase in these rates.Researchers from St. Michael's Hospital in Toronto studied almost 9,000 neighborhoods in Southern Ontario looking at walkability scores, along with government health data and survey...

Duration:00:01:00

Diabetes Research Suggests Better Long Term Outcomes with Early Insulin

11/30/2015
More
Host: Jennifer Caudle, DO Host Jennifer Caudel, DO welcomes Jay Shubrook, DO, Director of Clinical Research and Diabetes Services at Touro University-California College of Osteopathic Medicine. Recorded on site at the American Osteopathic Association's annual medical education conference, Dr. Shubrook discusses a pilot study in which newly diagnosed type 2 diabetes patients were treated with early insulin rather than lifestyle changes and oral therapies alone. The results suggested not only...

Duration:00:12:59

Injectable Medication as an Alternative Treatment for Diabetic Eye Disease

11/25/2015
More
[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the procedure has many side effects including permanent loss of peripheral vision and swelling of the retina.A group of researchers from across the US tested an alternative treatment using an injectable...

Duration:00:01:00

The Role of the Certified Diabetes Educator: A Team Effort

8/31/2015
More
Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integrations of certified diabetes educators to help empower diabetes patients and improve long-term outcomes. Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing...

Duration:00:16:29

Hot Topics in Diabetes: What Endocrinologists are Talking About

7/27/2015
More
Host: Brian P. McDonough, MD, FAAFP Dr. Brian McDonough welcomes Dr. Tina Thethi, Assistant Professor of Medicine in the section of Endocrinology and Metabolism at Tulane University Health Sciences Center. Dr. Thethi provides the inside scoop on diabetes topics of particular interest to endocrinologists in practice today, from pre-diabetes management to continuous glucose monitoring to novel drug research and development.

Duration:00:15:59

Regeneration of Insulin-Producing Islets in our Patients

11/2/2010
More
Guest: G. Alexander Fleming, MD Host: Bruce Bloom, DDS, JD Researchers are looking at hundreds of ways to treat and cure type one diabetes. Most of the advances so far have come in newly diagnosed children. Is there anything on the horizon to help adults with established type one diabetes? Dr. Alexander (Zan) Fleming, chairman and chief medical officer of Exsulin, joins host Dr. Bruce Bloom to discuss the new therapies for reversing established diabetes.

Duration:00:14:28

Biomolecular Advances in Diabetes Prevention

11/1/2010
More
Guest: Carmella Evans-Molina, MD, PhD Host: Bruce Bloom, DDS, JD As the epidemic of type 2 diabetes in the United States grows, researchers are investigating hundreds of ways to treat and cure diabetes. Some of these methods include exogenous insulin, while other ideas being explored require more complex changes in our understanding of cellular biology. Dr. Carmella Evans-Molina, assistant professor at the Indiana University School of Medicine, who holds a faculty appointment in the...

Duration:00:14:59

Cardiac Screening for Asymptomatic Patients With Diabetes

10/29/2010
More
Guest: Steven Wittlin, MD Host: Lee Freedman, MD It is often thought that patients with diabetes have more "silent" heart disease than patients without diabetes: Coronary artery disease is a leading cause of death among these patients. But is screening all asymptomatic patients with diabetes for the condition prudent, or should we exercise caution when considering cardiac screening? Dr. Steven Wittlin, associate professor of medicine and clinical director of the endocrine/metabolism...

Duration:00:14:29

Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression

10/28/2010
More
Guest: Christopher Slatore, MD Host: Mary Leuchars, MD Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with chronic obstructive pulmonary disease (or COPD)? Dr. Christopher Slatore, assistant professor in the division of pulmonary and critical care medicine, Portland VA Medical Center / Oregon Health and Sciences University, in Portland,...

Duration:00:14:29

The Hygiene Hypothesis and Risk of Type 1 Diabetes in Children

10/28/2010
More
Guest: Carolyn Paris, MD Host: Mary Leuchars, MD Improved living conditions and hygiene may be contributing to the rise of type 1 diabetes in children, but does the "hygiene hypothesis" fully explain the onset of type 1 diabetes in this population? What factors might explain the increased incidence of type 1 diabetes among pediatric patients in the US, Sweden and Finland, in particular? Dr. Carolyn Paris, pediatrician and emergency medicine specialist at the Center for Clinical and...

Duration:00:14:29

Weighing Metformin's Benefits & Risks in Patients With Renal Insufficiency

10/26/2010
More
Guest: Hugh Tildesley, MD Host: Lee Freedman, MD Metformin is often the first line of therapy for patients with type 2 diabetes: it is relatively inexpensive, available, and has proven efficacy. However, metformin is contraindicated for patients with renal insufficiency, a common comorbidity in diabetes. Do the benefits of metformin outweigh the risks for those with renal insufficiency, or should we use caution when considering metformin for these patients? Dr. Hugh Tildesley,...

Duration:00:14:29

The Cost of Diabetes to the Healthcare System

10/20/2010
More
Guest: Joanna Jiang, MD Host: Bruce Japsen The new health reform law will take steps to encourage patients to use preventive tests and screenings to head off chronic conditions, like diabetes, that extract a huge toll on the nation's medical care budget. Exactly how much does diabetes care cost the medical system, and where is the money going? Dr. Joanna Jiang, senior research scientist at the AHRQ (the Agency for Healthcare Research and Quality), tells host Bruce Japsen about the origin...

Duration:00:12:59